Indication
Vitamin D dependent rickets
Vitamin D dependent rickets refers to a group of rare, inherited metabolic bone disorders characterized by severe defects in vitamin D activation or end-organ responsiveness, primarily manifesting in infants and young children. Read more about Vitamin D dependent rickets
112 drugs 69 manufacturers
Drugs that treat it
Common Vitamin D dependent rickets therapies.
CHOLECALCIFEROL (VITAMIN D3)
VITAMIN D2 (ergocalciferol (vitamin D2))
ERGOCALCIFEROL (VITAMIN D2)
CHOLECALCIFEROL (VITAMIN D3)
REPLESTA NX (cholecalciferol (vitamin D3))
CHILDREN'S REPLESTA (cholecalciferol (vitamin D3))
VITAMIN D3 (cholecalciferol (vitamin D3))
D-2000 (cholecalciferol (vitamin D3))
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonVitamin D dependent rickets refers to a group of rare, inherited metabolic bone disorders characterized by severe defects in vitamin D activation or end-organ responsiveness, primarily manifesting in infants and young children.
The condition disrupts normal mineral homeostasis and skeletal mineralization, leading to hallmark features such as softening of the bones, bowed legs, metaphysical widening, growth delay, hypotonia, and dental anomalies.
Pathophysiologically, it is driven by genetic mutations affecting vitamin D hydroxylases, the vitamin D receptor, or related metabolic pathways, typically presenting with hypocalcemia, secondary hyperparathyroidism, and hypophosphatemia despite adequate nutritional vitamin D intake.
- medlineplus.gov
Vitamin D dependent rickets refers to a group of rare, inherited metabolic bone disorders characterized by severe defects in vitamin D activation or end-organ responsiveness, primarily manifesting in infants and young children The condition disrupts normal mineral homeostasis and skeletal mineralization, leading to hallmark features such as softening of the bones, bowed legs, metaphysical widening, growth delay, hypotonia, and dental anomalies
- nih.gov
Vitamin D dependent rickets refers to a group of rare, inherited metabolic bone disorders characterized by severe defects in vitamin D activation or end-organ responsiveness, primarily manifesting in infants and young children
- nih.gov
The condition disrupts normal mineral homeostasis and skeletal mineralization, leading to hallmark features such as softening of the bones, bowed legs, metaphysical widening, growth delay, hypotonia, and dental anomalies Pathophysiologically, it is driven by genetic mutations affecting vitamin D hydroxylases, the vitamin D receptor, or related metabolic pathways, typically presenting with hypocalcemia, secondary hyperparathyroidism, and hypophosphatemia despite adequate nutritional vitamin D int...
- nih.gov
Pathophysiologically, it is driven by genetic mutations affecting vitamin D hydroxylases, the vitamin D receptor, or related metabolic pathways, typically presenting with hypocalcemia, secondary hyperparathyroidism, and hypophosphatemia despite adequate nutritional vitamin D intake
- nih.gov
Pathophysiologically, it is driven by genetic mutations affecting vitamin D hydroxylases, the vitamin D receptor, or related metabolic pathways, typically presenting with hypocalcemia, secondary hyperparathyroidism, and hypophosphatemia despite adequate nutritional vitamin D intake
Personalize your experience
Follow Vitamin D dependent rickets and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.